The researchers found that over the seven-year-period, there was an association between levels of copeptin at the start of the study and the likelihood of later heart disease events. Once the data were adjusted for other influencing factors, the results indicated that patients were more than twice as likely to experience heart attack or stroke for every 1 pmol/L increase in blood copeptin levels.
- Type-2 diabetes affects about 60 million people in Europe and is associated with a number of debilitating conditions, including blindness and kidney failure.
- Type-2 diabetes can also increase the risk of coronary artery disease and stroke, which can lead to premature death.
- these results suggest that in type-2 diabetes patients, levels of copeptin can predict cardiovascular disease independently of well-established risk factors.
“Type-2 diabetes affects about 60 million people in Europe”